RESUMEN
Keppler-type ruthenium(III) complexes exhibit promising antitumor properties. We report here a study of 2-aminothiazolium[trans-tetrachlorobis(2-aminothiazole)ruthenate(III)], both in the solid state and in solution. The crystal structure has been solved and found to exhibit classical features. Important solvatochromic effects were revealed. Notably, we observed that introduction of an amino group in position 2 greatly accelerates chloride hydrolysis compared to the thiazole analogue; this latter finding may be of interest for a fine-tuning of the reactivity of these novel metallodrugs.
Asunto(s)
Antineoplásicos/farmacología , Compuestos Organometálicos/farmacología , Rutenio/química , Tiazoles/farmacología , Animales , Antineoplásicos/química , Cristalografía por Rayos X , Leucemia P388 , Conformación Molecular , Compuestos Organometálicos/química , Estereoisomerismo , Relación Estructura-Actividad , Tiazoles/química , Células Tumorales CultivadasRESUMEN
Two ruthenium(III) complexes bearing the thiazole ligand, namely, thiazolium (bisthiazole) tetrachlororuthenate (I, TzICR) and thiazolium (thiazole, DMSO) tetrachlororuthenate (II, TzNAMI) were prepared and characterized. The crystal structures of both complexes were solved by X-ray diffraction methods and found to match closely those of the corresponding imidazole complexes. The behavior in aqueous solution of bothTzICR and TzNAMI was analyzed spectroscopically. The time-dependent spectrophotometric profiles resemble closely those of the related ICR and NAMI-A anticancer compounds, respectively. It is observed that replacement of imidazole with thiazole, a less basic ligand, produces a significant decrease of the ligand exchange rates in the case of the NAMI-like compound. The main electrochemical features of these ruthenium(III) thiazole complexes were determined and compared to those of ICR and NAMI-A. Moreover, some preliminary data were obtained on their biological properties. Notably, both complexes exhibit higher reactivity toward serum albumin than toward calf thymus DNA; cytotoxicity is negligible in line with expectations. A more extensive characterization of the pharmacological properties in vivo is presently in progress.
Asunto(s)
Antineoplásicos/química , Compuestos Organometálicos/química , Rutenio/química , Tiazoles/química , Algoritmos , Animales , Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Cristalografía por Rayos X , Dimetilsulfóxido/síntesis química , Dimetilsulfóxido/química , Dimetilsulfóxido/farmacología , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Cinética , Modelos Moleculares , Compuestos Organometálicos/síntesis química , Compuestos Organometálicos/farmacología , Estereoisomerismo , Tiazoles/síntesis química , Tiazoles/farmacología , Células Tumorales CultivadasRESUMEN
The reaction of trans-[RuCl(2)(PPh(3))(3)] (Ph = C(6)H(5)) with 2-thio-1,3-pyrimidine (HTPYM) and 6-thiopurines (TPs) produced mainly crystalline solids that consist of cis,cis,trans-[Ru(PPh(3))(2)(N,S-TPYM)(2)] (1) and cis,cis,trans-[Ru(PPh(3))(2)(N(7),S-TPs)(2)]X(2) (X = Cl(-), CF(3)SO(3)(-)). In the case of TPs, other coordination isomers have never been isolated and reported. Instead, the mother liquor obtained after filtration of 1 produced red single crystals of trans,cis,cis-[Ru(PPh(3))(2)(N,S-TPYM)(2)].2H(3)O(+).2Cl(-) (2.2H(3)O(+).2Cl(-)). Selected ruthenium(II)-thiobase complexes were studied for their structural, reactivity, spectroscopic, redox, and cytotoxic properties. Single crystals of 1 contain thiopyrimidinato anions chelated to the metal center via N and S. The Ru[bond]N bonds are significantly elongated for 1 [2.122(2) and 2.167(2) A] with respect to 2 [2.063(3) A] because of the trans influence from PPh(3). The coordination pseudo-octahedron for 2 is significantly elongated at the apical sites (PPh(3) ligands). Solutions of cis,cis,trans isomers in air are stable for weeks, whereas those of 2 turn green within 24 h, in agreement with the respective redox potentials. cis,cis,trans- and trans,cis,cis-[Ru(PH(3))(2)(N,S-TPYM)(2)], as optimized through the DFT methods at the Becke3LYP level are in good agreement with experimental geometrical parameters (1 and 2), with cis,cis,trans being more stable than trans,cis,cis by 3.88 kcal. The trend is confirmed by molecular modeling based on semiempirical (ZINDO/1) and molecular mechanics (MM) methods. Cytotoxic activity measurements for cis,cis,trans-[Ru(PPh(3))(N-THZ)(N(7),S -H(2)TP)(2)]Cl(2) (4) (THZ = thiazole, H(2)TP = 6-thiopurine) and cis,cis,trans-[Ru(PPh(3))(2)(N(7),S-HTPR)2]Cl(2) (5) (HTPR = 6-thiopurine riboside) against ovarian cancer cells A2780/S gave IC(50) values of 17 +/- 1 and 29 +/- 9 microM, respectively. Furthermore, the spectral analysis of HTPYM, TPs, and their Ru(II) complexes in solution shows that intense absorptions occur in the UVA/vis region of light, whereas standard nucleobases absorb in the UVB region.
Asunto(s)
Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Compuestos Organometálicos/síntesis química , Compuestos Organometálicos/farmacología , Rutenio/química , Antineoplásicos/química , Supervivencia Celular/efectos de los fármacos , Cristalografía por Rayos X , Estabilidad de Medicamentos , Femenino , Humanos , Concentración 50 Inhibidora , Ligandos , Modelos Moleculares , Estructura Molecular , Compuestos Organometálicos/química , Neoplasias Ováricas/patología , Oxidación-Reducción , Fotoquímica , Pirimidinas/química , Estereoisomerismo , Células Tumorales CultivadasRESUMEN
The reaction of hemin with three well known artemisinin analogues, namely dihydroartemisinin, artemether and artesunate, was independently analysed by visible spectrophotometry and by ESI-MS/HPLC. A very similar reaction pathway emerges for all these compounds that matches closely the reaction profile previously described for artemisinin. In the course of the reaction characteristic isomeric 1:1 drug-hemin adducts are formed as in the case of artemisinin; eventual disruption of the porphyrin ring takes place in all cases, most likely through oxidative degradation.
Asunto(s)
Artemisininas/química , Hemina/química , Sesquiterpenos/química , Artemisininas/síntesis química , Cromatografía Líquida de Alta Presión , Estructura Molecular , Sesquiterpenos/síntesis química , Espectrometría de Masa por Ionización de Electrospray/métodos , Espectrofotometría , Relación Estructura-ActividadRESUMEN
The crystal structure of a complex of terbium(III) with quinizarine 2-sulfonate has been solved by single-crystal X-ray diffraction methods. The metal cation is coordinated by two adjacent phenolate and quinone oxygens of the anthraquinone moiety of a quinizarine sulfonate anion and by six water molecules. To our knowledge, this is the first structure of a metal complex of the 1,4-dihydroxy anthraquinone ligand. On the basis of strict similarities in the spectroscopic features of the terbium adducts with either doxorubicin or quinizarine 2-sulfonate, the present structure is proposed as a model for the metal complexes of anthracyclines.
RESUMEN
The interaction of the novel disaccharide anthracycline MEN 10755 with human serum albumin (HSA) was investigated by visible absorption and fluorescence spectroscopies and by ultrafiltration. Notably, MEN 10755 binds serum albumin far stronger than doxorubicin. Albumin binding results into a drastic quenching of the intrinsic fluorescence of MEN 10755; a binding constant of 1.1 x 10(5) was determined from fluorescence data. To localize the HSA binding site of MEN 10755 competition experiments were carried out with ligands that are selective for the different drug binding sites of the protein. No relevant competition effects were seen in the case of warfarin, diazepam and hemin, known ligands of sites I, II and III, respectively. Modest effects were observed following addition of palmitic acid that targets the several fatty acid binding sites of the protein. In contrast, extensive displacement of the bound anthracycline was achieved upon addition of ethacrinic acid. On the basis of these results, it is proposed that MEN 10755 binds serum albumin tightly to a non-canonical surface binding site for which it competes specifically with ethacrinic acid.
Asunto(s)
Antineoplásicos/metabolismo , Disacáridos/metabolismo , Doxorrubicina/análogos & derivados , Doxorrubicina/metabolismo , Albúmina Sérica/metabolismo , Algoritmos , Sitios de Unión , Humanos , Ligandos , Unión Proteica , Espectrometría de Fluorescencia , UltrafiltraciónRESUMEN
Slow decomposition of L-ascorbic acid, carried out under aerobic conditions and in the presence of cadmium ions, results in formation of a crystalline product that is highly insoluble in water. This compound has been identified as a cadmium oxalate polymeric species with formula Cd(C(2)O(4)).3H(2)O. The crystal structure of this compound is described. Relevant crystal data are the following: C(4)H(12)O(14)Cd(2), fw = 508.94; triclinic; space group P1 (No. 1); a = 6.010(1) A, b = 6.668(1) A, c = 8.498(1) A; alpha = 74.64(1) degrees, beta = 74.25(1) degrees, gamma = 80.91(1) degrees; V = 314.7(5) A(3); Z = 1.